Nestle acquires AIMMUNE’S Palforzia for $2.6 bn
THD NewsDesk, ZURICH, SWITZERLAND: Swiss food giant Nestlé acquired Aimmune Therapeutics Inc. closing the deal at $2.6 billion. Nestlé bought ...
THD NewsDesk, ZURICH, SWITZERLAND: Swiss food giant Nestlé acquired Aimmune Therapeutics Inc. closing the deal at $2.6 billion. Nestlé bought ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily